Menu
Xsensio wins TETRACOM grant
- Published on
- November 26, 2015
Xsensio is proud to announce that it is one of the few recipients of a TETRACOM grant given under the FP7 European program. The grant will speed up the collaboration between Xsensio and EPFL on the innovative nanofluidics skin interface.
Recent News
- XSENSIO ANNOUNCES KNOW-HOW AND STOCK PURCHASE AGREEMENT WITH MAYO CLINIC
- XSENSIO INVITED ON PODCAST “IMPULSE – MEETING HEALTHCARE PIONEERS”
- XSENSIO VOTED BEST PITCH BY DEEPTECH INVESTOR COMMUNITY AT INPHO VENTURE SUMMIT
- XSENSIO ON PODCAST “DART FOUNDER SERIES”
- NICOLA BRAMWELL JOINS THE BOARD OF DIRECTORS OF XSENSIO AS INDEPENDENT MEMBER
- XSENSIO WORKS WITH PHARMA COMPANY UCB TO INNOVATION ALONG THE PATIENT JOURNEY
- XSENSIO SELECTED BY THE MAYO CLINIC IN THE US TO JOIN COMPETITIVE ACCELERATOR PROGRAM
- XSENSIO RAISES CHF 4.2 MILLION IN A FIRST CLOSE
- XSENSIO FEATURED IN STARTUPTICKER.CH “SPORTS SCIENTISTS HAVE BEEN DREAMING OF THIS KIND OF CONTINUOUS DATA”
- XSENSIO MAKES 1st DEPLOYMENT AT MOTIONLAB
Share on linkedin
Share on twitter
CONTACT US
info@xsensio.com
EPFL Innovation Park
Building A
CH-1015 Lausanne
Switzerland
SIGN UP FOR OUR NEWSLETTER
Sign up for our newsletter to get reports of our most recent activity.